Status:
ACTIVE_NOT_RECRUITING
BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Johns Hopkins University
Conditions:
Blood Culture Rates
Antibiotic Stewardship
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will compare two strategies that target distinct determinants of blood culture overuse in an exploratory, hybrid, pilot trial in 8 PICUs. It aims to determine if there is any association be...
Detailed Description
Blood cultures are an important test to diagnose bacterial bloodstream infections, but can be ordered reflexively, excessively, and lead to downstream negative patient consequences such as unnecessary...
Eligibility Criteria
Inclusion
- Males or females over 18 years old
- PICU clinicians with direct patient care roles
Exclusion
- Non-English speaking
- PICU clinicians who report to the investigator
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06187662
Start Date
January 1 2023
End Date
April 1 2027
Last Update
October 31 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Mattel Children's Hospital
Los Angeles, California, United States, 90095
2
UCSF Benioff Children's Hospital Mission Bay
San Francisco, California, United States, 94158
3
Nemours / AI DuPont Hospital for Children
Wilmington, Delaware, United States, 19803
4
Riley Hospital for Children
Indianapolis, Indiana, United States, 46202